| The consequences of iron overdose and its treatment with desferrioxamine in pregnancy. | |
| | |
MedLine Citation:
|
PMID: 1679648 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A study was carried out to assess the effect on the outcome of pregnancy of iron overdose and its treatment with desferrioxamine. Sixty-eight cases were drawn from those reported to the United Kingdom National Poisons Information Centre and the Teratology Information Service at Guy's Hospital, London, and follow-up was obtained in 51 of these. Two were subsequently reported not to be pregnant and there were 49 records of pregnant patients who took iron overdoses and where outcome of the pregnancy was known. Twenty-five of these patients were treated with desferrioxamine. In 48 of the 49 patients the dose of iron allegedly taken was known and in 28 (60%) was over 20 mg kg-1, sufficient to put them at risk of toxicity. In the 36 whose serum iron levels were measured, 20 patients had levels in excess of 60 mumol l-1, indicating a risk of moderate or severe toxicity. Of the 49 pregnancies, 43 resulted in live babies, two had spontaneous abortions and there were four elective terminations. Of the live babies, three were premature, two of whom had problems, and there were three other babies with abnormalities. All babies with malformations were associated with overdoses after the first trimester and so the malformations cannot be directly related to the overdose. A total of 25 patients received desferrioxamine of whom two had malformed babies, but the desferrioxamine can be excluded as a cause. There was no correlation between the serum iron levels and the birthweights. In conclusion, iron overdose in pregnancy can be fatal and antidote treatment if appropriate should not be withheld.(ABSTRACT TRUNCATED AT 250 WORDS) |
| | |
Authors:
|
P R McElhatton; J C Roberts; F M Sullivan |
Related Documents
:
|
1618358 - Pregnancy in idiopathic aplastic anemia (report of 10 patients). 3603108 - Treatment of carpal tunnel syndrome with vitamin b6. 18977808 - Periconceptional maternal vitamin supplementation and childhood leukaemia: an uncertain... 9624108 - Agmatine suppresses proliferation by frameshift induction of antizyme and attenuation o... 22333968 - A comparative study of breastfeeding during pregnancy: impact on maternal and newborn o... 12396558 - The effect of prolonged cryopreservation on embryo survival. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Human & experimental toxicology Volume: 10 ISSN: 0960-3271 ISO Abbreviation: Hum Exp Toxicol Publication Date: 1991 Jul |
Date Detail:
|
Created Date: 1991-10-17 Completed Date: 1991-10-17 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 9004560 Medline TA: Hum Exp Toxicol Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 251-9 Citation Subset: IM |
Affiliation:
|
Department of Pharmacology and Toxicology, United Medical School (Guy's Hospital Campus), London, U.K. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Birth Weight Deferoxamine / therapeutic use* Female Humans Infant, Newborn Iron / blood, poisoning* Male Overdose / drug therapy, physiopathology Pregnancy Pregnancy Complications / drug therapy* Pregnancy Outcome |
| Chemical | |
Reg. No./Substance:
|
70-51-9/Deferoxamine; 7439-89-6/Iron |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Evidence of soil-pica behaviour and quantification of soil ingested.
Next Document: Computer prediction of possible toxic action from chemical structure; the DEREK system.